Peripheral Blood Smear Findings in COVID-19Letters to the Editor Published on 2020-12-192022-10-28 Journal: Turkish Journal of Hematology [Category] Coronavirus, SARS, [키워드] blood smears COVID-19 finding Morphology cells peripheral smear [DOI] 10.4274/tjh.galenos.2020.2020.0262 PMC 바로가기 [Article Type] Letters to the Editor
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trialCOVID-19에 대한 Arbidol(Umifenovir)의 효과: 무작위 대조 시험Randomized Controlled Trial Published on 2020-12-142022-08-13 Journal: BMC Infectious Diseases [Category] SARS, 임상, 치료제, [키워드] (Lopinavir/ritonavir adjusted Admission age Analysis antiviral drugs ARB Arbidol ARMS assigned Chest CT Clinical improvement contribute Corona virus cough COVID-19 COVID-19 disease criteria determine diagnosis of COVID-19 duration of hospitalization Dyspnea Effect effective Efficacy eligible patient ESR examined Fever Final final analysis followed by group groups Health Organization hospital Hospitalization Hydroxychloroquine ICU admissions IHD Improvements independent Kaletra Laboratory less Lopinavir Lopinavir/ritonavir male multicenter design Multiple linear regression multiple linear regression analysis Na level Open-label open-label randomized controlled trial oxygen oxygen saturation Patient patients with COVID-19 peripheral peripheral oxygen saturation Peripheral oxygen saturation rate Primary outcome Randomized controlled trial Randomly recruited relief Result Ritonavir Sample size significance level significantly supportive care Symptom the disease therapy time treatments for COVID-19 Trial registration two group two groups variable WBC WHO World Health Organization [DOI] 10.1186/s12879-020-05698-w PMC 바로가기 [Article Type] Randomized Controlled Trial
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel diseaseCOVID-19 치료 환자를 위한 Tocilizumab: 새로운 질병에 권장되는 약물Review Published on 2020-12-012022-09-12 Journal: International immunopharmacology [Category] MERS, SARS, 진단, 치료법, [키워드] actemra China Commission coronavirus disease COVID-19 CT scan disease drug Effect effective Efficacy Evidence fatal COVID-19 IMPROVE in some infected patients infiltration Inflammation introduced Iran lung tissue medication Patient patients patients with COVID-19 peripheral positive predicted provide reduced researcher respiratory inflammation saturation scientist Spread Tocilizumab treat Treatment virus with COVID-19 [DOI] 10.1016/j.intimp.2020.107018 PMC 바로가기 [Article Type] Review
Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and TransmissibilityCOVID-19 환자에서 SARS-CoV-2의 장기 존재: 숙주 면역, 바이러스 독성 및 전염성Article Published on 2020-12-012022-09-11 Journal: Virologica Sinica [Category] MERS, SARS, 변종, 진단, 치료기술, [키워드] antibody CD4 CD8 Cell cell supernatant cell supernatants Clinical characteristics clinically coding regions Cohort collected COVID-19 COVID-19 patient cured Cytopathic effect demographic demographic data detectable Existence favor Genome sequencing IFN-γ IgG initial symptom initial symptoms inoculated interferon gamma long-term lymphocyte Lymphocyte functionality Lymphocytes median median age Mild Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples neutralisation Neutralization antibody Neutralizing activity Neutralizing antibodies neutralizing antibody NK cell NK cells nucleic acid test passages pathogenicity Patient patients peripheral positive positively correlated SARS-CoV-2 SARS-CoV-2 clearance SARS-COV-2 infection SARS-CoV-2 nucleic acid SARS-CoV-2 virus Sequencing Spike protein synonymous variant Vero E6 Vero E6 cell VERO E6 cells Viral viral clearance Viral load viral pathogenicity [DOI] 10.1007/s12250-020-00308-0 PMC 바로가기 [Article Type] Article
Peripheral facial nerve palsy associated with COVID-19COVID-19와 관련된 말초 안면 신경 마비Article Published on 2020-12-012022-09-11 Journal: Journal of Neurovirology [Category] SARS, 치료기술, [키워드] added Bell Bell palsy Complete COVID-19 CSF eight facial Facial nerve facial nerve palsy Facial nerve. facial palsy FIVE Infection Laboratory mild dysfunction moderate nerve nerve damage neurological neurological manifestation neurological manifestations palsy pandemic Patient patients patients with COVID-19 PCR peripheral radiological feature radiological features Spectrum steroid Steroids Symptom Symptoms syndrome treated with COVID-19 [DOI] 10.1007/s13365-020-00912-6 PMC 바로가기 [Article Type] Article
Peripheral blood inflammatory markers in predicting prognosis in patients with COVID‐19. Some differences with influenza ACOVID-19 환자의 예후를 예측하는 말초 혈액 염증 마커. A형 인플루엔자와의 몇 가지 차이점Research Article Published on 2020-11-222022-08-31 Journal: Journal of Clinical Laboratory Analysis [Category] MERS, 바이오마커, [키워드] AST AUC Blood clinical Clinical data correlation COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 CREA D‐dimer Data collection electronic medical record enrolled evaluate forms hematologic hospital hsCRP IL‐6 individual Inflammation Inflammatory marker inflammatory markers Influenza influenza A intensity Local medical records Mild NLR Patient patients peripheral Peripheral blood positive correlation positive correlations predict Prognosis reflected Result SARS‐CoV‐2 SARS‐CoV‐2 infection SARS‐CoV‐2 virus SARS‐CoV‐2 sensitivity severity significantly SII specificity typing worse prognosis Wuhan [DOI] 10.1002/jcla.23657 PMC 바로가기 [Article Type] Research Article
Analysis of Peripheral Blood IL-6 and Leukocyte Characteristics in 364 COVID-19 Patients of WuhanImmunology Published on 2020-11-192022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] 1.26 2019 coronavirus disease age analyzed Blood can be used Characteristics Chinese correlation COVID-19 Critical Critical case decrease determine diagnosed with COVID-19 Diagnosis disease evaluate groups IL-6 individual infected with COVID-19 leukocyte leukocytes lymphocyte Lymphocytes Manifestations Mild monocyte Monocytes neutrophil Neutrophils Novel coronavirus pathogen Patient peripheral Peripheral blood Pneumonia pulmonary risk factor SARS coronavirus 2 SARS-CoV-2 serum severe COVID-19 severity of COVID-19 Treatment Wuhan [DOI] 10.3389/fimmu.2020.559716 PMC 바로가기 [Article Type] Immunology
Peripheral Neuropathy as a Complication of SARS-Cov-2Internal Medicine Published on 2020-11-122022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Analysis Awareness baseline Brain C-reactive protein cerebrospinal fluid Clinical outcome Complication Copper deficiency Corticosteroid cough COVID-19 creatinine kinase CSF described Diagnosis early treatment elevated lactate dehydrogenase fatigue fevers FIVE Guillain-barrè syndrome healthy intravenous Intravenous immunoglobulin lack magnetic resonance imaging management Methylprednisolone Mild myalgia nasal congestion neurologic neurological manifestation Neurological symptoms Neuropathy onset of symptoms Pain Patient patients peripheral Peripheral Neuropathy positive post-viral preserved replaced reported respiratory symptom SARS-CoV-2 serum shown sore throat spinal fluid steroid symptomatic improvement tested Treatment unlikely vitamin B6 was done weakness [DOI] 10.7759/cureus.11452 PMC 바로가기 [Article Type] Internal Medicine
Hydroxychloroquine Inhibits the Trained Innate Immune Response to InterferonsArticle Published on 2020-11-102022-10-31 Journal: Cell Reports Medicine [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Antiviral block Blood Candida cellular changes in Chloroquine conditioned coronavirus coronavirus disease COVID-19 COVID-19 patient dampen decreased expression Genes healthy donor Hydroxychloroquine Immunity Infection inhibit Innate innate immune innate immune cell innate immune memory innate immune response Innate immunity interferon interferon response interferon-stimulated genes interferons investigated leukocyte Ligand ligands lipidome lysine mechanism of action Modification modifications Monocytes mononuclear cell Patient patients PBMC PBMCs peripheral Peripheral blood Prophylactic receptor response SARS-CoV-2 SARS-COV-2 infection the interferon trained immunity [DOI] 10.1016/j.xcrm.2020.100146 PMC 바로가기 [Article Type] Article
Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19Medicine Published on 2020-10-142022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Biomarker Cell cells clinical feature common COVID-19 COVID-19 severity Fever Infection laboratory parameter Patient peripheral reported SARS-CoV-2 Severe respiratory distress severity syndrome [DOI] 10.3389/fmed.2020.580677 PMC 바로가기 [Article Type] Medicine